Publications for Michael Slater
Publications for Michael Slater
&list_uids=16613492">[More Information]</a>
2011
2005
Rybchyn, M., Slater, M., Conigrave, A., Mason,
R. (2011). An Akt-dependent increase in
canonical Wnt Signalling and a Decrease in
Sclerostin Protein Levels Are Involved in
Strontium Ranelate-induced Osteogenic Effects
in Human Osteoblasts. Journal of Biological
Chemistry, 286(27), 23771-23779. <a
href="http://dx.doi.org/10.1074/jbc.M111.25111
6">[More Information]</a>
Slater, M., Cooper, M., Murphy, C., Watson, G.
(2005). Adehesion molecules in endometriosis
and Endometrioid adenocarcinoma show altered
expressions suggesting a commonality between
these diseases. Journal of Histotechnology,
28(3), 185-190.
2007
Slater, M., Cooper, M., Murphy, C. (2007). The
cytoskeletal proteins alpha-actinin, Ezrin, and
talin are De-expressed in endometriosis and
endometrioid carcinoma compared with normal
uterine epithelium. Applied
Immunohistochemistry and Molecular
Morphology, 15(2), 170-174. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17525629">[More Information]</a>
2006
Slater, M., Murphy, C. (2006). Co-expression of
interleukin-6 and human growth hormone in
apparently normal prostate biopsies that
ultimately progress to prostate cancer using low
pH, high temperature antigen retrieval. Journal
of Molecular Histology, 37(1-2), 37-41. <a
href="http://dx.doi.org/10.1007/s10735-006-902
7-8">[More Information]</a>
Slater, M., Cooper, M., Murphy, C. (2006).
Human growth hormone and interleukin-6 are
upregulated in endometriosis and endometrioid
adenocarcinoma. Acta histochemica, 108(1),
13-18. <a
href="http://dx.doi.org/10.1016/j.acthis.2006.01.
004">[More Information]</a>
Gupta, R., Dixon, K., Deo, S., Holliday, C.,
Slater, M., Halliday, G., Reeve, V., Mason, R.
(2006). Photoprotection by 1,25
Dihydroxyvitamin D3 Is Associated with an
Increase in p53 and a Decrease in Nitric Oxide
Products. Journal of Investigative Dermatology.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17170736">[More Information]</a>
Reeve, V., Titmuss (nee Domanski), D., Slater,
M. (2006). Radiation sources providing
increased UVA/UVB ratios induce
photoprotection dependent on the UVA dose in
hairless mice. Photochemistry and Photobiology,
82(2), 406-411. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
Slater, M., Barden, J. (2005). Differentiating
keratoacanthoma from squamous cell carcinoma
by the use of apoptotic and cell adhesion
markers. Histopathology, 47(2), 170-178. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16045778">[More Information]</a>
Slater, M., Quagliotto, G., Cooper, M., Murphy,
C. (2005). Endometriotic cells exhibit
metaplastic change and oxidative DNA damage
as well as decreased function, compared to
normal endometrium. Journal of Molecular
Histology, 36(4), 257-263. <a
href="http://dx.doi.org/10.1007/s10735-005-380
2-9">[More Information]</a>
Slater, M., Danieletto, S., Barden, J. (2005).
Expression of the apoptotic calcium channel
P2X7 in the glandular epithelium. Journal of
Molecular Histology, 36(3), 159-165. <a
href="http://dx.doi.org/10.1007/s10735-004-616
6-7">[More Information]</a>
Slater, M., Lauer, C., Gidley-Baird, A., Barden,
J. (2005). Markers for the development of early
prostate cancer. In Hayat M (Eds.), Handbook
of Immunohistochemistry & in situ Hybridization
of Human Carcinomas, Vol. 2 (Molecular
Pathology, Colorectal Carcinoma and Prostate
Carcinoma), (pp. 335-346). New York: Elsevier.
Dixon, K., Deo, S., Wong, G., Slater, M.,
Norman, A., Bishop, J., Posner, G., Ishizuka, S.,
Halliday, G., Reeve, V., Mason, R. (2005). Skin
cancer prevention: A possible role of
1,25dihydroxyvitamin D3 and its analogs.
Journal of Steroid Biochemistry and Molecular
Biology, 97(1-2), 137-143. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16039116">[More Information]</a>
2004
Slater, M., Danieletto, S., Pooley, M., Teh, L.,
Gidley-Baird, A., Barden, J. (2004).
Differentiation Between Cancerous And Normal
Hyperplastic Lobules In Breast Lesions. Breast
Cancer Research and Treatment, 83(1), 1-10.
Slater, M., Danieletto, S., Gidley-Baird, A., Teh,
L., Barden, J. (2004). Early Prostate Cancer
Detected Using Expression Of Non-Functional
Cytolytic P2X7 Receptors. Histopathology,
Publications for Michael Slater
44(3), 206-215.
2003
Slater, M., Scolyer, R., Gidley-Baird, A.,
Thompson, J., Barden, J. (2003). Increased
expression of apoptotic markers in melanoma.
Melanoma Research, 13(2), 137-145.
Slater, M., Lauer, C., Gidley-Baird, A., Barden,
J. (2003). Markers for the development of early
prostate cancer. Journal of Pathology, 199(3),
368-377. <a
href="http://dx.doi.org/10.1002/path.1258">[Mo
re Information]</a>
2002
Slater, M., Brown, D., Husband, A. (2002). In
the prostatic epithelium, dietary isoflavones from
red clover significantly increase estrogen
receptor B and E - cadherin expression decrease
transforming growth factor B1. Prostate Cancer
and Prostatic Diseases, 5(1), 16-21.
Slater, M., Husband, A., Brown, D. (2002). In
the prostatic epithelium, dietry isoflavones from
red clover significantly increase estrogen
receptorB and E-cadherin expression but
decrease transforming growth factor B1. Prostate
Cancer and Prostatic Diseases, 5(1), 16-21.
Ray, F., Huang, W., Slater, M., Barden, J.
(2002). Purinergic receptor distribution in
endothelial cells in blood vessels: a basis for
selection of coronary artery grafts.
Atherosclerosis, 162(1), 55-61.
Slater, M., Murphy, C., Barden, J. (2002).
Purinergic receptor expression in the apical
plasma membrane of rat uterine eithelial cells
during implantation. Cell Calcium, 31(5),
201-207.
Slater, M., Murphy, C., Barden, J. (2002).
Tenascin, E-cadherin. Journal of Molecular
Histology, 34(1-2), 13-19.
2001
Slater, M., Murphy, C., Barden, J., Delprado, W.
(2001). Detection of preneoplasia in
histologically normal prostate biopsies. Prostate
Cancer and Prostatic Diseases, 4 (2), 92-96.